The Doctrine of Exhaustion and the Parallel Importation of MedicinesOctober 27, 2020
Complicating factors in patent enforcement are the different approaches adopted by developed and developing nations in addressing the doctrine of exhaustion of IP rights and the related concept of parallel trade.
Co-hosts Lisa Pensabene, head of O’Melveny’s Life Science Litigation practice, and Lisa Jakob, Managing Counsel, Trademark Group for Merck, will lead a panel discussion who will address recent legal developments related to the exhaustion doctrine and their impact on trade and access to medicine.
- Daniela Fasoli, Simões Intellectual Property (Brazil)
- Juanita Acosta, Dentons (Colombia and Andean Community)
- Teresa Summers, Summers Law Group (US/Canada)
- Louise Jonshammar, AWA Sweden AB (Europe)
- Anne Gustavsson, AWA Sweden AB (Europe)
- Carolina del Rio, Dentons (Chile and Mexico)
- Raquel Flanzbaum, Ojam Bullrich Flanzbaum (Argentina, Uruguay, Paraguay)
WhenTuesday, October 27
11:00 am - 1:00 pm ET
Via Webinar (details will be provided to registrants)
RSVPTo reserve your space, please contact Danielle Calhoun.
About WIN: The Women in IP Network
A new positive professional network of women IP lawyers to promote, support, teach and learn from each other. Our group was started by women lawyers to promote the success of other women lawyers, junior and senior, working in IP. This inclusive network was founded by women working in intellectual property law at pharmaceutical companies, communications companies, technology companies and law firms who believe that as each individual woman succeeds, all women will succeed. Find more information here.
Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.